These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Phase I study of weekly cisplatin, vinorelbine, and concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer. Kobayashi M, Matsui K, Hirashima T, Nitta T, Sasada S, Tada T, Minakuchi K, Furukawa M, Ogata Y, Kawase I. Int J Clin Oncol; 2006 Aug; 11(4):314-9. PubMed ID: 16937306 [Abstract] [Full Text] [Related]
23. Oral vinorelbine plus cisplatin followed by maintenance oral vinorelbine as first-line treatment for advanced non-small cell lung cancer. Farhat FS, Ghosn MG, Kattan JG. Cancer Chemother Pharmacol; 2015 Aug; 76(2):235-42. PubMed ID: 26024554 [Abstract] [Full Text] [Related]
24. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study. Carabante-Ocón F, Cobo-Dols M, Benavides-Orgaz M, Gil-Calle S, Alés-Díaz I, Bretón-García JJ, Villar-Chamorro E, Montesa-Pino A, Alcalde-García J, Gutiérrez-Calderón V. Clin Lung Cancer; 2005 Sep; 7(2):121-6. PubMed ID: 16179099 [Abstract] [Full Text] [Related]
25. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC. Lena MD, Ramlau R, Hansen O, Lorusso V, Wagner L, Barni S, Cristovao MM, Huber R, Alberola V, Mitrovic M, Colin C, Gasmi J. Lung Cancer; 2005 Apr; 48(1):129-35. PubMed ID: 15777980 [Abstract] [Full Text] [Related]
35. Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study. Beckmann G, Fietkau R, Huber RM, Kleine P, Schmidt M, Semrau S, Aubert D, Fittipaldo A, Flentje M. Onkologie; 2006 Apr; 29(4):137-42. PubMed ID: 16601369 [Abstract] [Full Text] [Related]
36. Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer. Masters GA, Hoffman PC, Hsieh A, Drinkard LC, Mick R, Samuels BL, Guaspari A, Golomb HM, Vokes EE. J Clin Oncol; 1997 Mar; 15(3):884-92. PubMed ID: 9060524 [Abstract] [Full Text] [Related]
37. Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer. Mizushima T, Tamagawa H, Matsuda C, Murata K, Fukunaga M, Ota H, Hasegawa J, Tsujie M, Fukuzaki T, Hata T, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. Oncology; 2015 Mar; 89(3):152-8. PubMed ID: 25967649 [Abstract] [Full Text] [Related]
38. A phase I study of UFT-oral vinorelbine in metastatic breast cancer. Ferrero JM, Largillier R, Michel C, Amiot V, Milano G, Hébert C, Mari V, Courdi A, Figl A, Follana P, Barrière J, Chamorey E. Oncology; 2011 Mar; 81(2):73-8. PubMed ID: 21968516 [Abstract] [Full Text] [Related]
40. Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. Leu KM, Kim KM, Larson M, Larson M, Schiller JH. Lung Cancer; 2001 Oct; 34(1):105-13. PubMed ID: 11557120 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]